WO2021161893A1 - Procédé d'analyse, système d'analyse et surface pour analyse - Google Patents

Procédé d'analyse, système d'analyse et surface pour analyse Download PDF

Info

Publication number
WO2021161893A1
WO2021161893A1 PCT/JP2021/004130 JP2021004130W WO2021161893A1 WO 2021161893 A1 WO2021161893 A1 WO 2021161893A1 JP 2021004130 W JP2021004130 W JP 2021004130W WO 2021161893 A1 WO2021161893 A1 WO 2021161893A1
Authority
WO
WIPO (PCT)
Prior art keywords
cell
molecule
analysis
linker
target capture
Prior art date
Application number
PCT/JP2021/004130
Other languages
English (en)
Japanese (ja)
Inventor
真寛 松本
和博 中川
Original Assignee
ソニーグループ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ソニーグループ株式会社 filed Critical ソニーグループ株式会社
Priority to EP21753086.4A priority Critical patent/EP4105340A4/fr
Priority to JP2022500356A priority patent/JPWO2021161893A1/ja
Priority to US17/760,350 priority patent/US20230066282A1/en
Priority to CN202180012867.7A priority patent/CN115052995A/zh
Publication of WO2021161893A1 publication Critical patent/WO2021161893A1/fr

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/02—Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Definitions

  • This technology relates to analytical methods, analytical systems, and analytical surfaces. More specifically, the present technology relates to an analytical method, an analytical system, and an analytical surface for obtaining the type and amount of components contained in a cell in association with the position information of the cell.
  • the type and amount of mRNA contained in the cells constituting the living tissue are measured.
  • the position information of the cell is also important. Therefore, several methods have been proposed so far for associating and acquiring the position information of cells contained in living tissues with the information of mRNA contained in the cells.
  • Non-Patent Document 1 discloses a method called Spatial transcriptomics. Probes used in this procedure include cleavage sites, T7 amplification and sequencing handles, Spatial barcodes, UMIs, and mRNA capture regions (FIG. 2 of the same article).
  • a tissue section is placed on a slide glass on which the probe is fixed, mRNA in the tissue section is captured by the molecule, and the cDNA is reverse transcribed to synthesize cDNA.
  • the synthesized cDNA is cleaved at the cleavage site, collected in a tube, and subjected to an analysis step such as sequencing.
  • an object of this technique is to provide a method capable of associating cell position information with cell components with single cell resolution.
  • the present technology includes an imaging step of imaging a sample in a state where a molecule containing a linker, a barcode sequence, and a target capture portion that can be cleaved by a stimulus is overlapped with a surface fixed via the linker.
  • the association step of associating the position of the cell with the barcode sequence of the molecule at the position
  • a cleavage step of selectively stimulating the position of the cell to cleave the linker of the molecule at the position A binding step of binding the molecule released from the surface by the cleavage to a component of the cell via a target capture portion of the molecule.
  • the specimen may include a tissue sample.
  • the position of the cell may be selectively stimulated so that the linker of the molecule at a position other than the position of the cell does not cleave.
  • the stimulus may be a light stimulus.
  • the binding step may include a moving step of moving the molecule towards the cell by applying an electric or magnetic field or centrifugal force.
  • the binding step may include a migration step of moving the molecule towards the cell by natural diffusion.
  • the binding step may include an incubation step for binding the molecule to the constituents of the cell.
  • the analytical method of the present technology may further include an analytical step of analyzing the conjugate of the molecule and the constituents of the cell after the binding step. In the analysis step, a sequencing treatment may be performed on the conjugate.
  • the analysis step may include a two-dimensional mapping step of performing two-dimensional mapping based on the association result in the association step using the analysis result and the sample image.
  • the present technology includes an analytical substrate having a surface in which a molecule containing a linker, a barcode sequence, and a target capture portion, which can be cleaved by a stimulus, is fixed via the linker.
  • An imaging device that captures a sample overlaid on the analysis substrate, and an imaging device.
  • An association part that associates the position of the selected cell in the sample image obtained by the imaging with the barcode sequence of the molecule at the position, and
  • a stimulus-imparting device that selectively stimulates the position of the cells, Including A conjugate in which a molecule released from the surface by the stimulus and a component of the cell are bound via a target capture portion of the molecule is used as an analysis target. It also provides an analysis system.
  • the specimen may include a tissue sample.
  • the stimulus-imparting device may be configured to selectively stimulate the position of the cell without cleaving the linker contained in the molecule at a position other than the position of the cell.
  • the stimulus applying device may be a light irradiation device.
  • the analysis system applies an electric field, a magnetic field, or a centrifugal force for moving the molecule released from the surface by the stimulation by the stimulation applying device toward the cell, or an electric field applying device or a magnetic field applying device or a centrifugal force. It may include an application device.
  • the analytical system may further include an incubation device for promoting the binding of the molecule released from the surface by the application of stimulation by the stimulation application device to the constituents of the cell.
  • the analysis system may further include an analyzer that analyzes the conjugate of the molecule and the constituents of the cell released from the surface by subjecting the stimulus by the stimulator.
  • the analyzer may be a sequencer.
  • the analysis system may further include a two-dimensional mapping unit that performs two-dimensional mapping based on the association result by the association unit using the analysis result by the analyzer and the sample image obtained by the imaging.
  • a molecule containing a cleaving linker, a barcode sequence, and a target capture part is fixed via the linker, and
  • the bar code sequence is used to provide information about the position where the molecule containing the bar code sequence is fixed.
  • a surface for analysis is also provided.
  • a specimen is imaged in a state where a molecule containing a linker, a barcode sequence, and a target capture part, which can be cleaved by a stimulus, is superimposed on a surface fixed via the linker. Then, using the sample image obtained by the imaging, the position of the cell contained in the sample is associated with the bar code sequence of the molecule at the position. After the association is made, the location of the cell to be analyzed is stimulated to cleave the linker of the molecule present at that location. The cleavage releases the molecule from the surface, and the molecule binds to the constituents of the cell to be analyzed via the target capture site.
  • the molecule thus bound to the constituents of the cell has a barcode sequence, and the barcode sequence is associated with the position of the cell. Therefore, by performing analysis on molecules bound to cell constituents (for example, identification of cell constituents and identification of barcode sequences), information on cell constituents is obtained in association with cell position information. be able to. Further, in the analysis method, a sample image is also acquired as described above. Therefore, for example, data on cell constituents can be mapped to a sample image.
  • the specimen may be an immobilized specimen, for example, a frozen section or an FFPE section.
  • the sample may be, for example, a tissue sample, and in particular, a living tissue sample.
  • the position of the cell is selectively stimulated, the molecule present at that position is released from the surface, and the molecule is bound to the constituent components of the cell. More preferably, in the cleavage step, the position of the cell is selectively stimulated so that the linker of the molecule at a position other than the position of the cell is not cleaved, whereby the cell composition at single cell resolution. It allows analysis of components (eg mRNA or protein). That is, the analysis method of the present technology may be an analysis method that analyzes the constituent components of cells contained in a specimen with single-cell resolution. Furthermore, the bar code sequence associated with the cell position information enables comprehensive analysis of the constituents of each cell for various cells contained in the sample.
  • a specific region can be designated based on the morphological information and immunostaining information of cells in the tissue sample, cut out with a laser or the like, and then subjected to mRNA analysis.
  • the expression information of mRNA in a tissue sample can be comprehensively performed for each cell contained in the tissue sample without cutting out the tissue sample.
  • the analysis method of the present technology may be an analysis method that analyzes the constituent components of a plurality of cells contained in a specimen with single-cell resolution.
  • Figure 1 shows an example of the flow chart of the analysis method of this technology.
  • the analysis method of the present technology may include an imaging target preparation step S101, an imaging step S102, an association step S103, a cleavage step S104, a coupling step S105, and an analysis step S106. These steps will be described below.
  • the imaging target in the imaging step S102 described later is prepared.
  • the imaging target may be a laminate obtained by stacking a sample on a surface in which a molecule containing a linker, a barcode sequence, and a target capture portion that can be cleaved by a stimulus is fixed via the linker.
  • an analytical substrate for example, a slide glass
  • a substrate on which the sample 103 is placed is a substrate on which the sample 103 is placed. It is superposed on 104 (eg, slide glass, etc.).
  • the superposition may be performed so that the surface 101 and the sample 103 face each other.
  • the surface 101 and the sample 103 may be brought into contact with each other via a buffer or the like.
  • the laminate of the analysis substrate 102 and the substrate 104 may be immersed in a buffer such as PBS.
  • the positional relationship between the substrates 102 and 104 can be fixed so that the positional relationship between the superposed surface 101 and the sample 103 is not changed in the steps described later (particularly, the imaging step S102 to the bonding step S105).
  • Molecule 100 includes a stimulatingly cleaveable linker, bar code sequence and target capture.
  • a molecule that is, a molecule containing the linker, the barcode sequence, and the target capture
  • the target-capturing molecule is a name used to mean a molecule used in the present technology, and is used in the present specification to refer to the molecule after capturing the target, for example, and a cleavage step described later. Can also be used to refer to the molecule after the linker has cleaved in.
  • the target capture molecule may be, for example, either a single molecule or a complex molecule.
  • a single molecule may mean, for example, one type of molecule having a plurality of functions, for example, as a nucleic acid portion configured as the linker, a nucleic acid moiety configured as the barcode sequence, and the target capture portion. It may be one nucleic acid (eg, DNA or RNA) containing the constituent nucleic acid moieties.
  • the complex molecule may be, for example, a molecular assembly composed of two or more kinds of molecules (for example, a conjugate of two or more kinds of molecules), for example, a nucleic acid portion configured as the linker and the barcode sequence.
  • the molecule 100 shown in FIG. 3 includes a linker 1, a recovery sequence section 2, an amplification sequence section 3, a barcode sequence section 4, a UMI (Unique molecular identifier) section 5, and a target capture section 6. Further, the molecule 100 is fixed to the surface 101 via the linker 1.
  • the recovery sequence part 2, the amplification sequence part 3, the barcode sequence part 4, and the UMI part 5 may be configured as a series of nucleic acids (particularly DNA).
  • the target capture unit 6 When the target capture unit 6 is a nucleic acid, in addition to the recovery sequence unit 2, the amplification sequence unit 3, the barcode sequence unit 4, and the UMI unit 5, the target capture unit 6 also has a series of nucleic acids (particularly, particularly). It may be configured as DNA). In these cases, for example, the end close to the fixed portion of the surface 101 and the molecule 100 may be the 5'end and the other end may be the 3'end. The components of the molecule 100 will be described below.
  • Linker 1 may be a linker that can be cleaved by a stimulus, for example, a linker that can be cleaved by a light stimulus or a temperature stimulus, and preferably a linker that can be cleaved by a light stimulus.
  • Photostimulation is particularly suitable for selectively stimulating a specific position in the cleavage step described below.
  • Linker 1 is any one selected from among arylcarbonylmethyl groups, nitroaryl groups, coumarin-4-ylmethyl groups, arylmethyl groups, metal-containing groups, and other groups, for example, as a linker that can be cleaved by photostimulation.
  • these groups for example, those described in Photoremovable Protecting Groups in Chemistry and Biology: Reaction Mechanisms and Efficacy, Chem. Rev. 2013, 113, 119-191 may be used.
  • the arylcarbonylmethyl group may be a phenacyl group, an o-alkylphenacyl group, or a p-hydroxyphenacyl group.
  • the nitroaryl group may be, for example, an o-nitrobenzyl group, an o-nitro-2-phenethyloxycarbonyl group, or an o-nitroanilide.
  • the arylmethyl group may be, for example, one in which a hydroxy group has been introduced or one in which no hydroxy group has been introduced.
  • the linker 1 When the linker 1 is a linker that can be cleaved by light stimulation, the linker may be cleaved by light having a wavelength of 360 nm or more.
  • the linker may preferably be a linker that is cleaved at an energy of 0.5 ⁇ J / ⁇ m 2 or less. (Light-sheet fluorescence microscopy for quantitative biology, Nat Methods. 2015 Jan; 12 (1): 23-6. Doi: 10.1038 / nmeth.3219.).
  • a linker that is cleaved by light of the above wavelength or the above energy it is possible to reduce cell damage (particularly DNA or RNA cleavage) that may occur when light stimulation is applied.
  • the linker 1 When the linker 1 is a linker that can be cleaved by a temperature stimulus, the linker 1 may contain, for example, a temperature-responsive polymer.
  • the temperature-responsive polymer can change from hydrophilic to hydrophobic or from hydrophobic to hydrophilic, for example, in response to temperature changes. Due to such changes, the target capture molecule can be released from surface 1.
  • the linker may be a linker that is cleaved by light in the short wavelength region, specifically, light in the wavelength region of 360 nm to 410 nm, or light in the near infrared region or infrared region, specifically. It may be a linker that is cleaved by light in a wavelength region of 800 nm or more. If the linker is a linker that is efficiently cleaved by light having a wavelength in the visible light region, it may be difficult to handle the surface for analysis. Therefore, the linker is preferably a linker that is cleaved by the light in the short wavelength region or the light in the near infrared region or the infrared region.
  • the recovery sequence unit 2 contains nucleic acid used for recovering the molecule 100 released from the surface 101 in the analysis step described later.
  • the nucleic acid may be DNA or RNA, in particular DNA.
  • the sequence of nucleic acid contained in the recovery sequence portion 2 is complementary to the sequence of nucleic acid 8 immobilized on the beads 9.
  • the bead 9 on which a plurality of nucleic acids 8 are immobilized can efficiently recover the molecule 100 having the recovery sequence portion 2.
  • the base sequence of the nucleic acid contained in the recovery sequence unit 2 may be appropriately set by those skilled in the art.
  • the amplification sequence unit 3 may include, for example, a nucleic acid having a primer sequence used for amplification of nucleic acid or a promoter sequence used for transcription of nucleic acid in the analysis step described later.
  • the nucleic acid may be DNA or RNA, in particular DNA.
  • the amplification sequence unit 3 may have both a primer sequence and a promoter sequence.
  • the primer sequence may be, for example, a PCR handle.
  • the promoter sequence may be, for example, a T7 promoter sequence.
  • the barcode sequence unit 4 contains a nucleic acid having a barcode sequence.
  • the nucleic acid may be DNA or RNA in particular, and more particularly DNA.
  • the barcode sequence is used, for example, to identify the location of the target capture molecule on the surface 101.
  • the barcode sequence can be used as an identifier to distinguish a target capture molecule containing a certain barcode sequence from a target capture molecule containing another barcode sequence.
  • the barcode sequence may be associated with information regarding the position where the target capture molecule containing the barcode sequence is fixed (hereinafter, also referred to as “position information”).
  • the position information may be for specifying a position on the surface 101, and is, for example, information about XY coordinates, but is not limited thereto.
  • An ID number may be assigned to the barcode array associated with the location information.
  • the ID number can be used in the steps after the imaging step.
  • the ID number may have a one-to-one correspondence with the bar code sequence, and may be used as data corresponding to the bar code sequence in the steps after the imaging step.
  • a plurality of target capture molecules immobilized in a certain region of the surface 101 may have the same barcode sequence.
  • the certain area is associated with the barcode sequence.
  • the target capture molecule containing the barcode sequence can be associated with the location of one cell.
  • the surface used in the analysis method of the present technology may have a plurality of regions in which a plurality of target capture molecules having the same barcode sequence are fixed.
  • the barcode array may be different for each region.
  • the size of each region can be preferably smaller than the size of the cells, for example 50 ⁇ m or less, preferably 10 ⁇ m or less, more preferably 5 ⁇ m or less.
  • a target capture molecule containing a barcode sequence of known sequence can be immobilized in a predetermined region.
  • the surface 101 has a plurality of regions, and a plurality of target capture molecules immobilized on each of the plurality of regions may contain the same barcode sequence.
  • the plurality of regions may be set smaller than the size of the cell to be analyzed.
  • each of the plurality of regions can be associated with the barcode sequence contained in the plurality of target capture molecules fixed in each region.
  • the region in which the target capture molecule containing the same barcode sequence is fixed is also referred to as a spot in the present specification.
  • the spot size can be, for example, 50 ⁇ m or less, preferably 10 ⁇ m or less, more preferably 5 ⁇ m or less.
  • the surface 101 configured as described above has a barcode sequence contained in a certain target capture molecule and a position where the target capture molecule exists at the time when the target capture molecule is immobilized on the surface 101. Can be associated with.
  • biotin is bound to the linker 1 of the target capture molecule and streptavidin is bound to the surface 101 on which the target capture molecule is fixed, and the biotin and the streptavidin are bound to each other.
  • the target capture molecule is immobilized on the surface 101.
  • target capture molecules containing a barcode sequence may be randomly placed on the surface 101.
  • the barcode contained in the fixed target capture molecule is read to read the barcode contained in a certain target capture molecule.
  • the sequence is associated with the location where the target capture molecule is located.
  • the reading can be performed by a method such as Sequencing By Synthesis, sequencing by ligation, or sequencing by hybridization.
  • beads for example, gel beads
  • the beads for example, gel beads
  • the size of the beads can be, for example, 50 ⁇ m or less, preferably 10 ⁇ m or less, more preferably 5 ⁇ m or less.
  • a combination of, for example, biotin and streptavidin may be used to attach the target capture molecule to the beads (eg, gel beads).
  • biotin is bound to the linker 1 of the target capture molecule
  • streptavidin is bound to the beads
  • the biotin and the streptavidin are bound to immobilize the target capture molecule on the beads.
  • the surface 101 may be provided with a plurality of recesses.
  • One spot or one bead according to the embodiment may be arranged in each of the plurality of recesses.
  • the spots or beads can be more easily placed on the surface 101 in the plurality of recesses.
  • the size of the recess is preferably a size in which one bead can be inserted, for example.
  • the shape of the recess may be circular, elliptical, hexagonal, or quadrangular, but is not limited thereto.
  • the surface state of the surface portion of the surface 101 on which the spot or the beads are arranged may be different from that of other surface portions.
  • the surface portion on which the spot or the beads are arranged may be hydrophilic and the other surface portion may be hydrophobic, or the other surface portion may be hydrophobic and have a convex portion. You may.
  • the method for imparting hydrophilicity to the surface include reactive ion etching in the presence of oxygen and irradiation with deep ultraviolet light in the presence of ozone. In these methods, a mask through which the portion imparting hydrophilicity is penetrated can be used.
  • a silicone spray spray-on-silicone
  • Techspray 2101-12S or the like
  • a mask through which the portion imparting hydrophobicity is penetrated can be used.
  • the target capture molecule can also be synthesized on a substrate by using, for example, a DNA microarray production technique.
  • a molecule for target capture can be synthesized at a specific position by using a technique such as DMD (Digital Mircomirror Device), a liquid crystal shutter, or a spatial optical phase modulator used in photolithography.
  • DMD Digital Mircomirror Device
  • a liquid crystal shutter or a spatial optical phase modulator used in photolithography.
  • the method for the synthesis is described in, for example, Basic Concepts of Microarrays and Potential Applications in Clinical Microbiology, CLINICAL MICROBIOLOGY REVIEWS, Oct. 2009, p. 611-633.
  • the target capture molecule When the target capture molecule is synthesized on the substrate by the synthesis, the information on the position where the target capture molecule is synthesized is acquired when the target capture molecule is synthesized, and the barcode sequence and the position information are obtained. Is associated with. At that time, an ID number may be assigned.
  • any of the target capture molecules immobilized on the surface may contain a common oligo sequence.
  • a nucleic acid having a sequence complementary to the oligo sequence and fluorescently labeled it is possible to confirm the position where the target capture molecule is fixed (particularly, the position of the spot or the position of the bead). It can be confirmed, especially in the dark field.
  • the fluorescent label makes it easy to grasp the position where the target capture molecule is fixed.
  • the UMI part 5 may contain nucleic acids, in particular DNA or RNA, and more particularly DNA.
  • the UMI part 5 may have a sequence of, for example, 5 to 30 bases, particularly 6 to 20 bases, and more particularly 7 to 15 bases.
  • the UMI part 5 may be configured to have different sequences from each other among the target capture molecules immobilized on the surface 101. For example, when the UMI part has a nucleic acid sequence of 10 bases, the type of UMI sequence is 4 to the 10th power, that is, 1 million or more.
  • the UMI part 5 can be used to quantify the target molecule. For example, a UMI sequence is added to the cDNA obtained by reverse transcription of mRNA.
  • cDNAs obtained by amplifying a cDNA transcribed from one mRNA molecule have the same UMI sequence, but many obtained by amplifying a cDNA transcribed from another mRNA molecule having the same sequence as the mRNA.
  • the cDNA has a different UMI sequence. Therefore, the number of copies of mRNA can be determined by counting the number of types of UMI sequences having the same cDNA sequence.
  • the UMI part 5 may be configured to have different sequences from each other among a plurality of target capture molecules containing the same barcode sequence immobilized on the spot or the beads. That is, the plurality of target capture molecules immobilized on the spot or the beads may have the same barcode sequence but different UMIs from each other.
  • the target capture unit 6 includes components for capturing molecules contained in cells.
  • the component can be, for example, a nucleic acid or protein.
  • the nucleic acid may be, for example, a poly T sequence in order to comprehensively capture the mRNA contained in the cell.
  • the nucleic acid may have a sequence complementary to the target sequence.
  • the component is a protein
  • the protein may be, for example, an antibody.
  • the component may be an aptamer or a molecularly imprinted polymer.
  • the target capture unit 6 may include two or more types of components for capturing molecules contained in cells.
  • the target capture unit 6 may contain both proteins and nucleic acids, for example both antibodies and poly T sequences. This allows both protein and mRNA to be detected simultaneously.
  • the surface 101 may preferably be the surface of a transparent substrate.
  • the substrate may be entirely transparent, or only the portion on which the target capture molecule is immobilized may be transparent.
  • the surface of the substrate is preferably flat in order to make good contact with the specimen.
  • the transparent substrate may be, for example, a glass substrate or a resin substrate.
  • the substrate may be, for example, a slide glass.
  • Specimen 4 may be, for example, a sample containing cells, and more particularly an immobilized sample containing cells.
  • the specimen may be a living tissue specimen, in particular a frozen tissue specimen or an FFPE (formalin-fixed paraffin-embedded) specimen, and more particularly a frozen tissue section or an FFPE section.
  • the sample 4 may be mounted on a substrate, for example, and may be a surface of a transparent substrate in particular.
  • the substrate may be entirely transparent, or only the portion on which the specimen is placed may be transparent.
  • the transparent substrate may be, for example, a glass substrate or a resin substrate.
  • the substrate may be, for example, a slide glass.
  • the surface of the substrate is preferably flat in order to make good contact with the surface on which the target capture molecule is immobilized.
  • Specimen 4 may be stained to facilitate the segmentation of cells described below.
  • the staining may be, for example, cell membrane staining, HE (Hematoxylin Eosin) staining, DAPI staining, or a combination of two or more of these.
  • HE Hematoxylin Eosin
  • DAPI staining a cell membrane staining reagent that is incorporated into a lipid bilayer and emits fluorescence may be used, and the reagent may be appropriately selected by those skilled in the art.
  • the HE stain is used for brightfield observation and can be used, for example, to identify cell morphology.
  • the DAPI staining can be used for nuclear staining.
  • the sample 103 is imaged in a state where the surface 101 and the sample 103 are overlapped with each other.
  • the imaging can be performed with a resolution that can be recognized by the individual cells contained in the sample 103.
  • the image sensor 110 may be, for example, a CCD or CMOS.
  • the image pickup may be performed by, for example, the image pickup element 110 via the objective lens 111. That is, the image captured can be a microscope image.
  • the magnification of the objective lens 111 may be appropriately selected according to the size of the cells.
  • the imaging may be an imaging in a bright field or a dark field, or both a bright field image and a dark field image may be performed.
  • the imaging may be performed once or multiple times, eg, once or multiple times for a portion of the area selected by the user or control unit, or to cover the entire or part of the sample 103. It may be performed once or multiple times.
  • the image pickup by the image pickup device 110 can be controlled by a control unit (not shown) connected to the image pickup device 110.
  • the control unit may be composed of, for example, a hard disk, a CPU, and a memory, and the function of the control unit can be realized by, for example, a general-purpose computer or an information processing device. Further, the control unit may be provided in the image pickup device 110.
  • the image pickup device including the control unit may be configured as, for example, a one-chip semiconductor device having a laminated structure in which a plurality of dies (for example, two or three dies) are laminated. One of the dies includes a plurality of pixels arranged two-dimensionally side by side.
  • the remaining dies may be equipped with components (eg, CPU and memory) for realizing the functions of the control unit.
  • the image sensor including the control unit for example, the image sensor disclosed in International Publication No. 2018/051809 can be mentioned.
  • an image sensor provided with a control unit as the image sensor, various processes can be performed without outputting the sample image data to the outside of the image sensor, which leads to high speed of information processing.
  • the image pickup device 110 can transmit the sample image data obtained by the image pickup to the control unit.
  • the control unit receives the sample image data and uses the sample image data in the subsequent steps. Further, the sample image data received by the control unit may be stored in, for example, a storage unit connected to the control unit.
  • the storage unit may be a general-purpose storage device. When the control unit performs the subsequent steps, the sample image data can be acquired from the storage unit.
  • the position of the cell and the bar code sequence of the target capture molecule at the position are associated with each other by using the sample image obtained by the imaging in the imaging step S102.
  • the association may be made via the location information previously associated with the barcode array.
  • the cell position and the ID number may be associated with each other. Thereby, the cell position and the barcode sequence can be associated with each other via the ID number.
  • the position of the cell may mean the area occupied by the cell in the sample image.
  • Image processing on the sample image may be performed to identify the region, for example cell segmentation.
  • Cell segmentation facilitates the identification of target-capturing molecules present at the location of the cell.
  • the position information of the cell to be analyzed among the cells in the sample image is acquired.
  • the cell position information may be acquired using the image data obtained by the above segmentation. Since the sample image is taken by superimposing the surface 101 and the sample 103, the position information of the cell corresponds to the position information of the target capture molecule at the position of the cell.
  • the position information of the target capture molecule is associated with the barcode sequence included in the target capture molecule in the imaging target preparation step S101. Therefore, by acquiring the position information of the cell in the sample image, the position of the cell can be associated with the barcode sequence contained in the target capture molecule at the position.
  • the association can be made so that one barcode sequence is not associated with the location of two or more cells.
  • one barcode sequence is not associated with the location of two or more cells.
  • the bar code sequence of the target capture molecule immobilized on the one spot is not associated with any position of the two or more cells.
  • the cells in the tissue sample can be visually recognized as shown in the center of FIG. It will be possible.
  • the specimen is imaged so as to be superimposed on the surface for analysis, and is imaged in a state where a large number of circular spots are overlapped, for example, as shown on the right side of FIG. In each circular spot, there are a plurality of target capture molecules having the same barcode sequence. On the right side of FIG. 4, a large number of circular spots are shown for better understanding, but these spots may not be visible or may be visible in the image acquired by the image sensor. When the position of the spot cannot be confirmed in the sample image, the position of the spot may be displayed in the sample image by image processing.
  • the association is performed with respect to the spot indicated by the solid circle. ..
  • the solid circle exists within the region of the image of one cell.
  • spots existing in the region of the image of one cell can be the target of association.
  • the dotted circle overlaps, for example, two or more cells, straddles the cell and the region outside the cell, or exists outside the region of the cell image. These dotted circles do not have to be associated.
  • the association step S103 can be performed, for example, by the control unit.
  • the control unit may associate the location of a cell with the bar code sequence of the molecule at the location of the cell for all or some of the cells present in the sample image.
  • the control unit can identify the cells with which the associations are made, for example, based on cell characteristics (shape, size, color, or pattern, or a combination thereof). For example, in the image shown in the center of FIG. 4, for the cell shown in dark gray, the cell position is associated with the bar code sequence of the target capture molecule at that position, while the cell shown in light gray.
  • the association may be made only for a specific type of cell, such as not making the association.
  • the association step S103 can be performed without outputting the sample image data to the outside of the image sensor. As a result, the association step S103 can be processed at a higher speed.
  • the association step S103 may be performed based on the user operation. For example, from among the cells existing in the sample image, the user selects the cells that he / she wishes to associate with, for example, by clicking the mouse. Then, for the cell selected by the user, the control unit can associate the position of the cell with the barcode sequence of the target capture molecule at the position.
  • the position of the cell is selectively stimulated to cleave the linker of the molecule at the position.
  • the stimulation applying device 130 can irradiate the position of the selected cell with light.
  • the position where the stimulus is given may be the position of a part of the cells associated in the association step S103, or may be the position of all the cells associated with the association.
  • the location of the cell is selectively stimulated so that the linker of the target capture molecule located at a location other than the location of the cell is not cleaved.
  • the stimulus-imparting device 130 is preferably configured to selectively irritate in this way. That is, in the cleavage step S104, the linker of the target capture molecule containing the unassociated barcode sequence does not have to be cleaved.
  • all the spots shown by the solid circles associated with each other may be stimulated.
  • stimulation may be applied to all positions of the associated cells.
  • it is shown at the position indicated by the solid circle spot in the cell indicated by dark gray, or by the solid circle spot in the cell indicated by light gray.
  • the stimulus may be given to the position where the stimulus is applied. In this way, the location of some of the associated cells (particularly certain types of cells) may be stimulated.
  • the stimulus is applied to the position indicated by the solid circle spot in one or more cells selected from the associated cells. You can. In this way, the position of some of the associated cells (particularly selected cells) may be stimulated.
  • Cleavage of the linker in step S104 releases the target capture molecule from the surface 101.
  • the cleavage of the linker 1 of the molecule 100 releases the molecule 100 from the surface 101.
  • the stimulus may be, for example, a light stimulus or a temperature stimulus (also referred to as a thermal stimulus), and may be a light stimulus.
  • Light stimulation is particularly suitable for selectively stimulating a specific narrow area.
  • the cleavage step S104 may be performed by, for example, the control unit. More specifically, the control unit can drive a stimulus-imparting device to selectively irradiate a cell position.
  • a stimulus applying device that can be adopted will be described below.
  • a light irradiation device can be used as the stimulation application device 130.
  • the light irradiation device may be, for example, a DMD (Digital Micromirror Device) or a liquid crystal display device.
  • the micromirrors that make up the DMD can irradiate a selected position on the surface 101 with light.
  • the liquid crystal display device may be, for example, a reflective liquid crystal display, and SXRD (Sony Corporation) can be mentioned as a specific example. By controlling the liquid crystal of the liquid crystal display device, it is possible to irradiate a selected position on the surface 101 with light.
  • a liquid crystal shutter or a spatial light modulator may be used to selectively apply light stimulation to the position of cells. These also make it possible to give a light stimulus to the selected position.
  • the wavelength of the irradiated light may be appropriately selected by those skilled in the art depending on the type of linker contained in the target capture molecule.
  • a combination of infrared light and an infrared light absorbing material can be used to selectively give a temperature stimulus to the cell position.
  • an infrared laser light generator can be adopted as the stimulus applying device.
  • a substrate 102 having a surface 101 is formed from an infrared light absorbing material, and the cell position is selectively irradiated with infrared light by an infrared laser light generator, thereby selectively stimulating the cell position with temperature. Can be given.
  • the target capture molecule released from the surface 101 by cleavage in step S104 is bound to the constituent components of the cell via the target capture portion of the target capture molecule.
  • the cell component 7 can bind to the target capture portion 6 of the target capture molecule 100 in the cell.
  • the binding step S105 may include a moving step of moving the target capturing molecule toward the cell by applying an electric field, a magnetic field, or a centrifugal force.
  • an electric field can be applied by arranging a laminate of substrates 102 and 104 between facing electrodes.
  • a metal thin film having a thickness that does not interfere with bright-field observation or dark-field observation (particularly fluorescence observation) or a transparent electrode such as ITO (Indium Tin Oxide) may be arranged on the substrate 102 and the substrate 104.
  • a device known in the art may be adopted as an electric field applying device for applying an electric field, a magnetic field applying device for applying a magnetic field, or a centrifugal force applying device for applying a centrifugal force.
  • the centrifugal force applying device include a swing rotor type centrifugal force applying device.
  • the application of electric or magnetic fields or centrifugal force by these devices may be controlled by, for example, a control unit.
  • the binding step S105 may include a transfer step of moving the target capture molecule toward the cell by natural diffusion.
  • a transfer step of moving the target capture molecule toward the cell by natural diffusion.
  • the transfer step preferably comprises applying an electric field, which can increase the probability that the liberated target capture molecule will be incorporated into the cell.
  • the binding step S105 may include an incubation step for binding the target capture molecule to the constituents of the cell.
  • the time and temperature of the incubation step may be selected depending on the target capture unit and the cell components captured by the target capture unit.
  • the incubation step can be performed, for example, with the surface 101 and the sample filled with a buffer.
  • the target capture unit and the cell constituent are both nucleic acids, for example, in a constant temperature bath at 30 ° C. to 40 ° C., particularly 30 ° C. to 37 ° C., for example, 5 hours to 30 hours, particularly 16 hours to Incubation can be done in 24 hours.
  • the target capture unit is an antibody and the cell component is a component captured by the antibody, for example, at 0 ° C. to 30 ° C., particularly 4 ° C. to room temperature (for example, 25 ° C.), for example, 5 hours. Incubation can be performed for up to 30 hours, especially 16 to 24 hours.
  • the target capture molecule may be taken up into the cell or may bind to the cell surface. Then, the target capture molecule binds to a component of the cell via the target capture portion of the target capture molecule. The surface 101 and the sample 103 are then separated and the unbound target capture molecules are removed by washing. As a washing method, the sample 103 may be immersed in a buffer or the like.
  • the conjugate produced by the binding of the target capture molecule and the cell constituent in the binding step S105 can be analyzed.
  • analysis can be performed using the analyzer 200.
  • a sequencing process may be performed on the conjugate, and the analyzer 200 may be a sequencer.
  • the sequencing process can be performed, for example, when the cell component is a nucleic acid, particularly DNA or RNA, more particularly mRNA.
  • the sequencing process may be performed by a sequencer, or may be performed by a next-generation sequencer or a sequencer by the Sanger method. In order to perform comprehensive analysis of the cells constituting the tissue at a higher speed, the sequencing process can be performed by a next-generation sequencer.
  • the analysis step may further include a step of preparing a nucleic acid (for example, cDNA) to be sequenced and a step of purifying the nucleic acid.
  • a library for performing next-generation sequencing treatment may be prepared.
  • recovery sequence 2 can be used, for example, as shown in FIG. 3 (D).
  • the molecule 100 to which the cell constituent 7 is bound can be recovered by using the beads 9 on which the nucleic acid having a sequence complementary to the nucleic acid sequence contained in the recovery sequence portion 2 is fixed.
  • the laminate of the substrates 102 and 104 after binding in the binding step S105 can be washed with a buffer such as PBS to remove unbound target capture molecules. Then, the substrate 102 is removed from the substrate 104, and the cells incorporating the target capture molecule may be subjected to, for example, a cDNA synthesis step of synthesizing cDNA from mRNA and an amplification step of amplifying the synthesized cDNA. .. Prior to the cDNA synthesis step and the amplification step, a lysis step of lysing the cells may be performed. By recovering the conjugate of the target capture molecule and the target after the dissolution step, the cDNA synthesis step and the amplification step can be performed more efficiently.
  • a buffer such as PBS
  • a purification step of purifying the nucleic acid obtained in the preparation step may be performed.
  • the purification step may include decomposition treatment of components other than nucleic acids using an enzyme such as proteinase K.
  • a nucleic acid recovery process may be performed in the purification step.
  • a commercially available nucleic acid purification reagent may be used, and examples thereof include magnetic beads such as AM PureXP.
  • intracellular dsDNA can also be recovered, but dsDNA can be prevented from being sequenced in the sequencing process. For example, by including the adapter sequence for sequencing processing (particularly for next-generation sequencing processing) in the target capture molecule, only the nucleic acid containing the adapter sequence can be sequenced.
  • the cell constituents can be analyzed for each cell based on the result of the sequencing treatment. For example, in the analysis step S106, the sequence of mRNA contained in the cell and / or the number of copies of each mRNA can be determined for each cell. Further, in the analysis step S106, the type and / or number of antigens or the type and / or number of transcription factors can be determined for each cell. Such analysis of cell components for each cell can be performed based on the barcode sequence in the sequence determined by the sequence treatment. For example, an array containing the same barcode sequence is selected from a large number of sequences determined by sequence processing. Sequences containing the same barcode sequence are based on target capture molecules incorporated into a single cell. Therefore, analyzing the cell constituents for each barcode sequence means analyzing the cell constituents for each cell.
  • the analysis step S106 may include a two-dimensional mapping step of performing two-dimensional mapping based on the association result in the association step S103 using the analysis result and the sample image.
  • the analysis result of the cell constituents for each cell can be mapped to the sample image obtained in the imaging step based on the position information associated with the barcode sequence.
  • the mapping for example, as shown in FIG. 2 (E), a sample image (above (E) in FIG. 2) and a mapping image showing the distribution of types of cell constituents at each position in the sample image ( (Under (E) in FIG. 2) can be obtained. From the image obtained by the mapping, it is possible to grasp which cell at which position contains which molecule and in what amount. That is, it is possible to combine the position information obtained by imaging and the quantitative information obtained by sequence analysis, and it is possible to comprehensively analyze the molecules in the tissue sample while retaining the spatial information by single cell resolution.
  • Figure 5 shows an example of a block diagram of the analysis system of this technology.
  • the analysis system 10 of the present technology includes an analysis substrate 102, an image sensor 110, a control unit 120, a storage unit 125, and a stimulus application device 130.
  • the analysis substrate 102, the image sensor 110, and the stimulus applying device 130 are described in the above 1. It may be as described in the above, and the description also applies to the present embodiment.
  • the control unit 120 is described in 1. above. It may be the control unit described in the above, and the description also applies to the present embodiment.
  • the control unit 120 may include, for example, an image processing unit 121, an association unit 122, and a stimulus control unit 123. These will be described in more detail below.
  • the image processing unit 121 processes the sample image acquired by the image sensor 110.
  • the image processing unit 121 is, for example, described in 1. above.
  • the cell segmentation described in the above can be performed.
  • the image processing unit 121 can identify the cells to be associated in the association step from the cells existing in the sample image.
  • the identification can be made, for example, based on cell characteristics (shape, size, color, or pattern, or a combination thereof).
  • the identification may be performed based on the color data in the image. For example, a cell that emits a certain fluorescence can be identified as a cell to be associated in the association step.
  • the association unit 122 associates the position of the cell with the bar code sequence of the target capture molecule at the position of the cell.
  • the association may be made using the image obtained by the above segmentation. For example, the association unit 122 acquires cell position data based on a sample image, identifies a barcode sequence to which position data corresponding to the position data is assigned, and associates the barcode sequence with the cell position. sell.
  • the association unit 122 may associate the position of a cell with the bar code sequence of the target capture molecule at the position of the cell for all cells in the sample image, or some cells in the sample image. You may go about. For example, the association unit 122 may make the association only for some types of cells among all the cells existing in the sample image, or may make the association only for the cells existing in a part region.
  • the stimulus control unit 123 causes the stimulus applying device 130 to selectively stimulate the position of the cell associated with the association unit 122.
  • the stimulus control unit 123 may drive the stimulus application device 130 to stimulate all or a part of the cells associated by the association unit 122.
  • the stimulus-imparting device 130 is preferably configured to selectively stimulate the cell position without cleaving the linker contained in the target capture molecule at a position other than the cell position. ..
  • the stimulus applying device 130 preferably has the above 1. This is the light irradiation device described in the above.
  • the control unit 120 may be composed of, for example, a hard disk, a CPU, and a memory, and the function of the control unit can be realized in, for example, a general-purpose computer or an information processing device.
  • the functions of the image processing unit 121, the association unit 122, and the stimulus control unit 123 can also be realized by a general-purpose computer or an information processing device.
  • the control unit 120 may be provided in the image sensor 110.
  • an image sensor provided with a control unit as the image sensor, various processes can be performed without outputting the sample image data to the outside of the image sensor, which leads to high speed of information processing.
  • the processing by the image processing unit 121, the association unit 122, and the stimulus control unit 123 described above can be performed at higher speed.
  • an electric field or a magnetic field for moving the target capture molecule released from the surface of the analysis substrate 102 toward the cell by applying the stimulus by the stimulus application device 130 is applied. It may include an electric or magnetic field applying device or a centrifugal force applying device that applies centrifugal force. The device allows the target capture molecule to be more efficiently taken up by the cell.
  • the analysis system 10 is described in 1. above.
  • the incubation device may include, for example, a constant temperature bath.
  • the analysis system 10 is described in 1. above.
  • an analyzer for analyzing the conjugate of the target capture molecule released from the surface of the analysis substrate 102 and the cell constituent component by the application of the stimulus by the stimulus application device 130 may be further included.
  • the analyzer can be, for example, a sequencer.
  • the sequencer may be, for example, a next-generation sequencer or a sequencer that performs sequencing by the Sanger method.
  • the analysis system 10 may further include a two-dimensional mapping unit that performs two-dimensional mapping based on the association result by the association unit using the analysis result by the analyzer and the sample image.
  • the two-dimensional mapping unit may be configured as one element of the control unit 120, for example, 1.
  • the two-dimensional mapping step described in the above can be performed.
  • the two-dimensional mapping unit can map information about, for example, cell components to a sample image.
  • the information about the constituents of the cell may be, for example, the type or amount of the constituents of the cell. From the image obtained by the mapping, it is possible to grasp which cell at which position contains which molecule and in what amount. That is, it is possible to combine the position information obtained by imaging and the quantitative information obtained by sequence analysis, and it is possible to comprehensively analyze the molecules in the tissue sample while retaining the spatial information by single cell resolution.
  • the analysis system 10 may further include an output unit.
  • the output unit may include, for example, a display device and / or a printing device.
  • the control unit 120 can output an image obtained by performing an analysis method according to the present technology, such as a sample image acquired by the image sensor 110 and a mapping image generated by the two-dimensional mapping unit, to the output unit. Further, the control unit 120 can output the analysis result (for example, the sequencing processing result) by the analyzer to the output unit.
  • a target capture molecule containing a cleavable linker, a barcode sequence, and a target capture portion is fixed via the linker, and the barcode sequence is a molecule containing the barcode sequence.
  • an analytical surface used to provide information about the fixed position. Examples of the surface for analysis include the above 1. It is the surface 101 of the analysis substrate 102 described in the above, and the description of the surface also applies to the present embodiment.
  • the present technology can also have the following configuration.
  • An imaging step in which a sample is imaged in a state where a molecule containing a linker, a barcode sequence, and a target capture portion that can be cleaved by a stimulus is overlapped with a surface fixed via the linker.
  • the association step of associating the position of the cell with the barcode sequence of the molecule at the position
  • a cleavage step of selectively stimulating the position of the cell to cleave the linker of the molecule at the position.
  • a binding step of binding the molecule released from the surface by the cleavage to a component of the cell via a target capture portion of the molecule.
  • Analytical methods including.
  • [2] The analytical method according to [1], wherein the sample contains a tissue sample.
  • [3] The analysis according to [1] or [2], wherein in the cleavage step, the position of the cell is selectively stimulated so that the linker of the molecule at a position other than the position of the cell is not cleaved. Method.
  • [4] The analysis method according to any one of [1] to [3], wherein the stimulus is a light stimulus.
  • the binding step includes a moving step of moving the molecule toward the cell by applying an electric field, a magnetic field, or a centrifugal force.
  • [6] The analysis method according to any one of [1] to [4], wherein the binding step includes a moving step of moving the molecule toward the cell by natural diffusion.
  • [9] The analysis method according to [8], wherein the sequencing process is performed on the conjugate in the analysis step.
  • Analysis system [12] The analytical system according to [11], wherein the sample contains a tissue sample. [13] The stimulus-imparting device is configured to selectively stimulate the position of the cell without cleaving the linker contained in the molecule at a position other than the position of the cell. [11] ] Or [12].
  • the analysis system according to any one of [11] to [13], wherein the stimulus applying device is a light irradiation device.
  • An electric field or magnetic field or a magnetic field applying device for applying an electric field, a magnetic field, or a centrifugal force for moving the molecules released from the surface by the stimulation applied by the stimulation applying device toward the cells.
  • the analytical system further includes an incubation device for promoting the binding of the molecule released from the surface by the stimulus applied by the stimulus-imparting device to the constituents of the cell [11] to [15]. ]
  • the analysis system further includes an analyzer that analyzes a combination of the molecule released from the surface and a constituent of the cell by applying a stimulus by the stimulus-imparting device [11] to [16].
  • the analysis system described in any one of. [18]
  • the analysis system further includes a two-dimensional mapping unit that performs two-dimensional mapping based on the association result by the association unit using the analysis result by the analysis device and the sample image obtained by the imaging. 17] or [18].
  • a molecule containing a cleavable linker, a barcode sequence, and a target capture part is fixed via the linker, and The bar code sequence is used to provide information about the position where the molecule containing the bar code sequence is fixed. Analytical surface.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Electromagnetism (AREA)
  • Sustainable Development (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

Le but de la présente invention est de fournir une technique qui permet d'associer des informations de position d'une cellule à un composant cellulaire par dissociation monocellulaire. 　Cette technologie concerne un procédé d'analyse comprenant: une étape d'imagerie consistant à capturer par imagerie un échantillon dans un état dans lequel l'échantillon est superposé sur une surface à laquelle des molécules comprenant chacune un lieur clivable par stimulation, une séquence de code à barres, et une partie de capture de cible sont immobilisées par l'intermédiaire du lieur ; une étape d'association consistant à associer la position d'une cellule à la séquence de code à barres d'une molécule à la position à l'aide d'une image d'échantillon obtenue par l'imagerie ; une étape de clivage consistant à cliver le lieur de la molécule à la position en appliquant sélectivement une stimulation à la position de la cellule ; et une étape de liaison consistant à lier la molécule libérée de la surface par le clivage à un composant constitutif de la cellule par l'intermédiaire de la partie de capture de cible de la molécule.
PCT/JP2021/004130 2020-02-14 2021-02-04 Procédé d'analyse, système d'analyse et surface pour analyse WO2021161893A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP21753086.4A EP4105340A4 (fr) 2020-02-14 2021-02-04 Procédé d'analyse, système d'analyse et surface pour analyse
JP2022500356A JPWO2021161893A1 (fr) 2020-02-14 2021-02-04
US17/760,350 US20230066282A1 (en) 2020-02-14 2021-02-04 Analysis method, analysis system, and analysis surface
CN202180012867.7A CN115052995A (zh) 2020-02-14 2021-02-04 分析方法、分析系统及分析表面

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020023365 2020-02-14
JP2020-023365 2020-02-14

Publications (1)

Publication Number Publication Date
WO2021161893A1 true WO2021161893A1 (fr) 2021-08-19

Family

ID=77291444

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/004130 WO2021161893A1 (fr) 2020-02-14 2021-02-04 Procédé d'analyse, système d'analyse et surface pour analyse

Country Status (5)

Country Link
US (1) US20230066282A1 (fr)
EP (1) EP4105340A4 (fr)
JP (1) JPWO2021161893A1 (fr)
CN (1) CN115052995A (fr)
WO (1) WO2021161893A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022190733A1 (fr) * 2021-03-10 2022-09-15 ソニーグループ株式会社 Procédé d'analyse de particules biologiques, et kit de réactifs pour analyse de particules biologiques
WO2023188896A1 (fr) * 2022-03-29 2023-10-05 ソニーグループ株式会社 Système d'analyse de bioparticules, dispositif de traitement d'informations et procédé d'analyse de bioparticules

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018051809A1 (fr) 2016-09-16 2018-03-22 ソニーセミコンダクタソリューションズ株式会社 Dispositif de capture d'image, et appareil électronique
US20180305681A1 (en) * 2015-10-28 2018-10-25 Silicon Valley Scientific, Inc. Method and apparatus for encoding cellular spatial position information
WO2018232396A1 (fr) * 2017-06-16 2018-12-20 The Jackson Laboratory Dosages d'interaction de chromatine de noyau unique et de molécule unique
WO2019079399A1 (fr) * 2017-10-20 2019-04-25 Duke University Dispositifs, systèmes et procédés pour analyse de cellule unique à haut débit

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11053536B2 (en) * 2012-07-30 2021-07-06 Hitachi, Ltd. Tag-sequence-attached two-dimensional CDNA library device, and gene expression analysis method and gene expression analysis apparatus each utilizing same
CA2993463A1 (fr) * 2015-07-27 2017-02-02 Illumina, Inc. Cartographie spatiale d'informations de sequence d'acide nucleique
GB201619458D0 (en) * 2016-11-17 2017-01-04 Spatial Transcriptomics Ab Method for spatial tagging and analysing nucleic acids in a biological specimen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180305681A1 (en) * 2015-10-28 2018-10-25 Silicon Valley Scientific, Inc. Method and apparatus for encoding cellular spatial position information
WO2018051809A1 (fr) 2016-09-16 2018-03-22 ソニーセミコンダクタソリューションズ株式会社 Dispositif de capture d'image, et appareil électronique
WO2018232396A1 (fr) * 2017-06-16 2018-12-20 The Jackson Laboratory Dosages d'interaction de chromatine de noyau unique et de molécule unique
WO2019079399A1 (fr) * 2017-10-20 2019-04-25 Duke University Dispositifs, systèmes et procédés pour analyse de cellule unique à haut débit

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
"Basic Concepts of Microarrays and Potential Applications in Clinical Microbiology", CLINICAL MICROBIOLOGY REVIEWS, October 2009 (2009-10-01), pages 611 - 633
"Photoremovable Protecting Groups in Chemistry and Biology: Reaction Mechanisms and Efficacy", CHEM. REV., vol. 113, 2013, pages 119 - 191
NAT METHODS., vol. 12, no. 1, January 2015 (2015-01-01), pages 23 - 6
PATRIK L. STAHL ET AL.: "Visualization and analysis of gene expression in tissue sections by spatial transcriptomics", SCIENCE, vol. 353, 1 July 2016 (2016-07-01), pages 78 - 82, XP002784680, DOI: 10.1126/science.aaf2403
See also references of EP4105340A4

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022190733A1 (fr) * 2021-03-10 2022-09-15 ソニーグループ株式会社 Procédé d'analyse de particules biologiques, et kit de réactifs pour analyse de particules biologiques
WO2023188896A1 (fr) * 2022-03-29 2023-10-05 ソニーグループ株式会社 Système d'analyse de bioparticules, dispositif de traitement d'informations et procédé d'analyse de bioparticules

Also Published As

Publication number Publication date
US20230066282A1 (en) 2023-03-02
JPWO2021161893A1 (fr) 2021-08-19
EP4105340A4 (fr) 2023-08-09
EP4105340A1 (fr) 2022-12-21
CN115052995A (zh) 2022-09-13

Similar Documents

Publication Publication Date Title
US20230313279A1 (en) Methods of determining the location of an analyte in a biological sample using a plurality of wells
US20230203478A1 (en) Methods, compositions, and systems for capturing probes and/or barcodes
JP5878154B2 (ja) ２次元ｃＤＮＡライブラリを用いた遺伝子発現解析方法
WO2021161893A1 (fr) Procédé d'analyse, système d'analyse et surface pour analyse
CN105026562B (zh) 基因定量、序列分析用二维细胞阵列器件及装置
EP3336199B1 (fr) Procédé de séquençage à molécule unique, dispositif, système, et application
JP3711988B2 (ja) 微粒子アレー分析システム、微粒子アレーキットおよび化学分析方法
WO2015097858A1 (fr) Dispositif d'analyse de biomolécule
US20240026446A1 (en) Systems and methods for spatial screening of analytes
EP3268715A1 (fr) Système et méthodes de coloration et d'imagerie en série
WO2022009642A1 (fr) Système et procédé d'analyse de bioparticules
JP5663008B2 (ja) 核酸分析デバイスの製造方法
AU2022296056A1 (en) Spatial analysis of a planar biological sample
US20180299360A1 (en) Methods for selectively analyzing biological samples
WO2020129462A1 (fr) Procédé de vérification de particules, puce permettant la capture de particules et système d'analyse de particules
JP2000279169A (ja) ポリヌクレオチド分離方法および装置
JP4475478B2 (ja) 遺伝子解析方法及び装置
US11692191B2 (en) Method for separating, capturing, analyzing and retrieving cells and cell products by using microstructure
JP2024519113A (ja) 生物学的試料中の単一細胞を位置特定及びプロファイリングするための方法及び構築体
US20230314327A1 (en) Systems and methods for nearly isotropic optical resolution using tilted structured illumination microscopy
CN111699255B (zh) 基于生物反应器的生物样品分析方法、分析芯片及分析系统
WO2022190733A1 (fr) Procédé d'analyse de particules biologiques, et kit de réactifs pour analyse de particules biologiques
WO2024141901A1 (fr) Transfert à chaud de produits de réaction fabriqués in situ sur un support plan
Certa et al. Biosensors in biomedical research: Development and applications of gene chips
JP2001037477A (ja) 座標付き繊維集合体薄片及び該薄片の製造方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21753086

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2022500356

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2021753086

Country of ref document: EP

Effective date: 20220914